Abstract
Mycoplasma pneumoniae pneumonia (MPP) is a common respiratory infection, particularly among children, accounting for 10% to 40% of community-acquired pneumonia cases worldwide. The increasing prevalence of macrolide-resistant strains, especially in China where resistance rates exceed 90%, has led to prolonged fever, poor treatment response, and increased complications, posing significant clinical challenges.In recent years, traditional Chinese medicine (TCM) external therapies—such as acupoint application, tuina (Chinese therapeutic massage), and moxibustion—have gained attention as complementary interventions for MPP. These therapies are widely used in clinical practice and are often administered by nurses as part of TCM nursing interventions. Accumulating evidence suggests that TCM external therapies may shorten disease duration, reduce inflammatory responses, and improve clinical outcomes. However, the current body of evidence on TCM external therapies for MPP remains fragmented. Numerous clinical studies exist, yet they vary considerably in study design, intervention protocols, outcome measures, and methodological quality. No comprehensive synthesis has systematically mapped the available evidence to identify research gaps, characterize intervention patterns, or assess the quality of existing studies. This fragmentation limits the ability of clinicians, nurses, and guideline developers to make informed decisions.Evidence mapping is an emerging evidence synthesis approach that systematically collects, categorizes, and visualizes existing research on a specific topic. Unlike traditional systematic reviews, evidence mapping does not typically pool effect sizes. Instead, it provides an overview of the evidence landscape, including study characteristics, intervention types, outcome indicators, and methodological quality, thereby identifying knowledge clusters and gaps.